Stage IV Non-small Cell Lung Cancer (NSCLC)

Oncology
1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Nektar Therapeutics
Nektar TherapeuticsSAN FRANCISCO, CA
1 program
1
Pegylated IrinotecanPhase 21 trial
Active Trials
NCT02312622CompletedEst. Jul 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Nektar TherapeuticsPegylated Irinotecan

Clinical Trials (1)

NCT02312622Nektar TherapeuticsPegylated Irinotecan

Phase 2 Etirinotecan Pegol in Refractory Brain Metastases & Advanced Lung Cancer / Metastatic Breast Cancer

Start: Aug 2015Est. completion: Jul 2019
Phase 2Completed

Related Jobs in Oncology

Senior Research Associate, Immuno-Oncology

SystImmune
16m ago
$60K - $85K/yr

Research Associate I/II, Immuno-Oncology

SystImmune
16m ago

Office Administrator

SystImmune
16m ago
$60K - $80K/yr

Scientist/Sr Scientist

TwoStep Therapeutics
San Carlos
27m ago

Working Student Office Management Support (m/f/d)

Mindpeak
Hamburg
30m ago

Senior Medical Project Manager (m/f/d)

Mindpeak
Hamburg
30m ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space

Related Indications

Breast Cancer(530)Non-small Cell Lung Cancer(373)Prostate Cancer(371)Multiple Myeloma(244)Advanced Solid Tumors(221)Acute Myeloid Leukemia(204)Cancer(187)Neoplasms(173)Colorectal Cancer(166)Advanced Solid Tumor(165)